Center for Health Equity Research and Promotion
Walid Gellad, MD, MPH
CHERP COIN Investigator
Staff Physician, VA Pittsburgh Healthcare System
Professor of Medicine, University of Pittsburgh School of Medicine
Professor of Health Policy and Management, University of Pittsburgh Graduate School of Public Health Director
Profile
Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients, optimizing the quality, safety, and value of prescribing and prescription drug use. He is a nationally recognized authority on improving the measurement of medication adherence, has authored more than 100 articles in leading medical and policy journals, and he is a regular commentator on pharmaceutical policy issues in major news outlets including the New York Times, Washington Post, and NPR, and the Wall Street Journal.
He was the recipient of a career development award from the Department of Veterans Affairs to study the quality and efficiency of prescribing in the VA and continues to lead research funded by the VA, NIH, CDC, and the state of Pennsylvania on multiple studies of pharmaceutical policy and prescription use. His work spans clinical areas, from diabetes, to Hepatitis C, to prescription drug and substance abuse. His policy area of expertise is prescription drug pricing and spending. He is a former member of the Food and Drug Administration (FDA) advisory committee on nonprescription drugs and currently an alternate member of the FDA Drug Safety Oversight Board.
Dr. Gellad is board certified in internal medicine and completed a residency and chief residency in internal medicine at Brigham and Women's Hospital and Harvard Medical School. He sees primary care patients in the VA Pittsburgh Heathcare System and attends on the inpatient general medical service.
Research Areas |
Pharmacy Policy |
Physician Prescribing Practices |
Awards |
Career Development Award |
Presidential Early Career Award for Scientists and Engineers |
News of Note
- Dr. Gellad was honored with a 2019 Presidential Early Career Award for Scientists and Engineers.
- CBS Pittsburgh News story
- Dr. Gellad's work comparing outcomes for Veterans who are covered by both VHA and Medicare Part D shows significantly higher risk for death from prescription opioids.
- Read about Dr. Gellad's publication with Secretary Shulkin in the Journal of General Internal Medicine
- Read profile of Dr. Gellad in Genetic Engineering & Biotechnology News
Funded Research
- STORM Implementation Program Evaluation (SDR 16-193) as Principal Investigator